In response to widespread apprehension regarding Thrombosis with Thrombocytopenia Syndrome (TTS), a rare complication associated with the Covishield COVID-19 vaccine, the Serum Institute, the
In response to widespread apprehension regarding Thrombosis with Thrombocytopenia Syndrome (TTS), a rare complication associated with the Covishield COVID-19 vaccine, the Serum Institute, the